Escamilla, Veronica
Alker, Alisa
Dandalo, Leonard
Juliano, Jonathan J.
Miller, William C.
Kamthuza, Portia
Tembo, Tapiwa
Tegha, Gerald
Martinson, Francis
Emch, Michael
Hoffman, Irving F.
Funding for this research was provided by:
PATH Malaria Vaccine initiative
GlaxoSmithKline Biologicals SA
Bill and Melinda Gates Foundation
National Institutes of Health (NIH 5 T32AI07001-36, R24 HD050924)
GlaxoSmithKline post-graduate fellowship
Article History
Received: 28 November 2016
Accepted: 8 March 2017
First Online: 7 April 2017